...
首页> 外文期刊>BMC Infectious Diseases >Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB?+?patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras
【24h】

Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB?+?patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras

机译:与保健工作者相比,洪都拉斯结核病患者的血液中IFN-γ和IL-17产生对结核分枝杆菌靶标的不同细胞识别模式:洪都拉斯患者的结核病和免疫反应

获取原文

摘要

Background A better understanding of the quality of cellular immune responses directed against molecularly defined targets will guide the development of TB diagnostics and identification of molecularly defined, clinically relevant M.tb vaccine candidates. Methods Recombinant proteins (n?=?8) and peptide pools (n?=?14) from M. tuberculosis (M.tb) targets were used to compare cellular immune responses defined by IFN-γ and IL-17 production using a Whole Blood Assay (WBA) in a cohort of 148 individuals, i.e. patients with TB?+?(n?=?38), TB- individuals with other pulmonary diseases (n?=?81) and individuals exposed to TB without evidence of clinical TB (health care workers, n?=?29). Results M.tb antigens Rv2958c (glycosyltransferase), Rv2962c (mycolyltransferase), Rv1886c (Ag85B), Rv3804c (Ag85A), and the PPE family member Rv3347c were frequently recognized, defined by IFN-γ production, in blood from healthy individuals exposed to M.tb (health care workers). A different recognition pattern was found for IL-17 production in blood from M.tb exposed individuals responding to TB10.4 (Rv0288), Ag85B (Rv1886c) and the PPE family members Rv0978c and Rv1917c. Conclusions The pattern of immune target recognition is different in regard to IFN-γ and IL-17 production to defined molecular M.tb targets in PBMCs from individuals frequently exposed to M.tb. The data represent the first mapping of cellular immune responses against M.tb targets in TB patients from Honduras.
机译:背景技术对针对分子确定的靶标的细胞免疫反应质量的更好理解将指导结核病诊断的发展和分子确定的,临床相关的M.tb疫苗候选物的鉴定。方法使用结核分枝杆菌(M.tb)靶标的重组蛋白(n?=?8)和肽库(n?=?14)比较IFN-γ和IL-17产生的细胞免疫应答148名患者的血液分析(WBA),即TB?+?(n?=?38)患者,TB-患有其他肺部疾病的患者(n?=?81)和暴露于TB而无临床证据的患者结核病(医护人员,n?=?29)。结果在暴露于M的健康个体的血液中,经常会识别出M.tb抗原Rv2958c(糖基转移酶),Rv2962c(霉菌基转移酶),Rv1886c(Ag85B),Rv3804c(Ag85A)和PPE家族成员Rv3347c,根据IFN-γ的产生.tb(卫生保健工作者)。对于暴露于TB10.4(Rv0288),Ag85B(Rv1886c)和PPE家族成员Rv0978c和Rv1917c的M.tb暴露个体的血液中的IL-17生产,发现了不同的识别模式。结论从经常暴露于M.tb的个体中,针对PBMC中确定的分子M.tb目标的IFN-γ和IL-17产生,免疫目标识别的模式有所不同。数据代表来自洪都拉斯的结核病患者针对M.tb靶标的细胞免疫应答的第一个图谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号